drugset / Trial / NCT03591289

Does Depth of Neuromuscular Blockade (NMB) Affect Surgical Conditions in Obese Patients Undergoing Robotic Surgery

NCT03591289 ↗

Phase 4 Withdrawn Rainer Lenhardt
RandomizedParallel-groupTriple-blindTreatment

Summary

A prospective, randomized, outcome trial to evaluate, if depth of neuromuscular blockade (NMB) will affect surgical conditions and postoperative pain based on the degree of neuromuscular block during robotic surgery for gynecological and urologic procedures in obese and non-obese patients.

Timeline

Start
2018-02
Primary completion
2018-02
Completion
2018-07-12

Outcome

Outcome not reported

Stopped: “study never started up at site”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rocuronium Other / unclassified 0.6 mg/kg —
Comparator Sugammadex Other / unclassified 2 mg/kg —
Comparator Sugammadex Other / unclassified 4 mg/kg —